Global Centre for Environmental Remediation, University of Newcastle, NSW 2308, Australia; Cooperative Research Centre for Contamination Assessment and Remediation of the Environment (CRC CARE), University of Newcastle, NSW 2308, Australia.
Department of Agro-Food Safety, National Institute of Agricultural Science, Wanju, Jeollabuk-do 55365, Republic of Korea.
Chemosphere. 2017 Sep;182:433-440. doi: 10.1016/j.chemosphere.2017.04.126. Epub 2017 May 3.
In many countries, rice grains and complementary medicines are important sources of arsenic (As) consumption. The objective of this study was to compare the speciation and bioaccessibility of As in selected rice grains and complementary medicines. A number of rice grain samples, and a range of herbal and ayurvedic medicines were analyzed for total As, speciation of As using sequential fractionation and extended x-ray absorption fine structure (EXAFS) techniques, and bioaccessibility of As using an in vitro extraction test. The daily intake of As through the uptake of these As sources was compared with the safety guidelines for As. The results demonstrated higher levels of As in ayurvedic medicines compared to herbal medicines and rice grains. The sequential fractionation showed the dominance of organic-bound As species in rice grains and herbal medicines, however, inorganic-bound As species dominated the ayurvedic medicines. This implies that As is derived from plant uptake in herbal medicines and rice grains, and from inorganic mineral input in ayurvedic medicines. Arsenic bioaccessibility was higher in ayurvedic than herbal medicines and rice grains, suggesting that inorganic As added as a mineral therapeutic input is more bioaccessible than organic As species derived from plant uptake. This study also showed a positive relationship between soluble As fractions and bioaccessibility indicating that solubility is an important factor controlling bioaccessibility. The daily intake values for As as estimated by total As content are likely to exceed the safe threshold level in rice grains that are enriched with As.
在许多国家,米粒和补充药物是砷(As)摄入的重要来源。本研究的目的是比较选定的米粒和补充药物中砷的形态和生物可利用性。对一些米粒样本以及一系列草药和阿育吠陀药物进行了总砷分析、砷形态的分步提取和扩展 X 射线吸收精细结构(EXAFS)技术分析,以及砷的生物可利用性的体外提取试验分析。通过吸收这些砷源来摄入砷的每日摄入量与砷的安全指南进行了比较。结果表明,与草药相比,阿育吠陀药物中的砷含量更高。分步提取显示,有机结合的砷形态在米粒和草药中占主导地位,而无机结合的砷形态在阿育吠陀药物中占主导地位。这意味着砷是从草药和米粒中的植物吸收以及阿育吠陀药物中的无机矿物输入中获得的。与草药和米粒相比,阿育吠陀药物中的砷生物可利用性更高,这表明作为矿物治疗输入添加的无机砷比源自植物吸收的有机砷形态更具生物可利用性。本研究还表明,可溶性砷与生物可利用性之间存在正相关关系,这表明溶解度是控制生物可利用性的重要因素。通过总砷含量估算的砷日摄入量可能会超过富含砷的米粒的安全阈值。